Furthermore, we identified independent predictors for ROS1 rearrangement, built prediction model for ROS1-rearranged NSCLCs by multiple logistic regression analysis, and tested the performance of prediction model on a new cohort of 57 lung adenocarcinomas (53 ROS1- and 4 ROS1+). This evidence concerns the gene ROS1 and lung adenocarcinoma.